Parmax Pharma Share Price

CMP as on11-Jun-21 15:27

₹ 71.90
3.4 4.96%

Open

₹ 71.90

Turnover (lac)

Prev. Close

₹ 68.50

Day's Vol (shares)

₹ 8,203

Day's Range

₹ 70.00
₹ 71.90

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Feb-2021 - -
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve we would like to inform you that the Meeting of the Board of Directors of Parmax Pharma Limited will be held on Friday, 12th February, 2021 In continuation of our Corporate announcement dated 4th February, 2021 we hereby inform you that the Board of Directors of the Company has, at its meeting held today, inter-alia, considered and approved: i. Unaudited Financial Results for quarter and Nine months ended 31st December, 2020. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and nine months ended 31st December, 2020. We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter and nine months ended 31st December, 2020 and Board has also taken on record their Limited Review Report on said Results. The meeting was commenced at 4.30 pm and was concluded at 5:45 pm. Since publications are closed on 14th February, 2021, hence our results can only be published on its next day i.e. 15th February 2021. Outcome of the meeting of the Board of Directors (As Per BSE Announcement dated on 12.02.2021)
Board Meeting - 09-Jan-2021 - -
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on the Saturday, 16th January 2021 inter alia to consider and approve the following businesses: 1. To approve the Preferential issue, Quantum and Determination of Issue Price of Securities. 2. To appoint Registered valuer and Merchant Banker for determining the issue price. 3. Any other business with the consent of Board. Outcome of Board Meeting dated 16th January, 2021 (As Per BSE Announcement dated on 16.01.2021)
Board Meeting - 05-Nov-2020 - -
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to notify that a meeting of the Board of Directors of the Company is proposed to be held on Thursday, the 12th November, 2020 at 2:00 P.M. to, inter-alia, consider, approve and take on the record the Un-audited Financial Results for the quarter and half year ended 30th September, 2020. This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 12th November, 2020, inter-alia, considered and approved the Unaudited Financial Results for quarter and half year ended 30th September, 2020. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and half year ended 30th September, 2020, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. The meeting commenced at 2:00 pm and concluded 6:40 pm. We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter ended and half year ended 30th September, 2020 and Board has also taken on record their Limited Review Report on said Results. (As per BSE Announcement Dated on 12/11/2020)
Board Meeting - 09-Sep-2020 - -
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve With reference to the captioned subject, we would like to inform you that the Meeting of the Board of Directors of Parmax Pharma Limited will be held on Tuesday, 15th September, 2020 at 02.00 PM inter alia to consider, approve the Unaudited Financial Results for the quarter ended 30th June, 2020 and to discuss any other matter with the permission of Board. You are requested to kindly take the above information on your record. This is to inform you that the Board of Directors of the Company has, at its meeting held today, inter-alia, considered and approved the Unaudited Financial Results for quarter ended 30th June, 2020. A copy of the Statement of Unaudited Financial Results for the quarter ended 30th June, 2020, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. The meeting was concluded on 6:45 pm. Further to inform you that the 26th Annual General Meeting of the Company will be held on Friday, 16th October, 2020 at the registered office of the Company. (As per BSE Announcement Dated on 15/9/2020)
Board Meeting - 24-Jul-2020 - -
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to notify that a meeting of the Board of Directors of the Company is proposed to be held on Friday, the 31st July, 2020 at 2:00 P.M. to, inter-alia, consider, approve and take on the record the Audited Financial Results for the year ended 31st March, 2020. Audited Financial Results for Quarter and Year Ended 31st March, 2020 (As Per BSE Announcement dated on 31.07.2020)
Open ZERO Brokerage Demat Account